Items where Author is "Ramesh, PM"

Choudhary, H and Malik, G and Chauhan, DS and Bhalla, M and Dusthackeer, A and Desikan, P and Giri, S and Kumar, S and Jayaprakasam, M and Singh, AV and Sethi, P and Reza, MS and Mythily, V and Thiyagarajan, V and Panwalkar, N and Tripathy, J and Mani, D and Singh, D and Ramesh, PM and Chalga, MS and Rani, R and Gupta, N and Pandey, RM and Singh, M (2025) Multicentric validation of the PathoDetect™ MTB RIF & INH assay for simultaneous detection of Mycobacterium tuberculosis, & drug resistance to rifampicin & isoniazid in presumptive pulmonary tuberculosis & drug-resistant TB patients. Multicentric validation of the PathoDetect™ MTB RIF & INH assay for simultaneous detection of Mycobacterium tuberculosis, & drug resistance to rifampicin & isoniazid in presumptive pulmonary tuberculosis & drug-resistant TB patients, 161(5) (482490).

Perumal Kannabiran, Bhavani and Alangudi Palaniappan, Natarajan and Manoharan, Tamizhselvan and Paramasivam, Paulkumaran and Subramanyam, Balaji and Ramesh, PM and Natarajan, Saravanan and Ammayappan, Radhakrishnan and Ganesan, Mangalambal and Angamuthu, Dhanalakshmi and Chinnaiyan, Ponnuraja and Chandrasekaran, Padmapriyadarsini (2024) Safety and Efficacy of 25 mg/kg and 35 mg/kg vs 10 mg/kg Rifampicin in Pulmonary TB: A Phase IIb Randomized Controlled Trial. Safety and Efficacy of 25 mg/kg and 35 mg/kg vs 10 mg/kg Rifampicin in Pulmonary TB: A Phase IIb Randomized Controlled Trial, 11(3) (ofae03).

Malaisamy, Muniyandi and Ramesh, PM and Wells, WA and Alavadi, Umesh (2023) The Cost-Effectiveness of the BEAT-TB Regimen for Pre-Extensively Drug-Resistant TB. The Cost-Effectiveness of the BEAT-TB Regimen for Pre-Extensively Drug-Resistant TB, 8 (411). pp. 1-10.